Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol versus carvedilol for orthostatic hypotension in hypertensive adults with type 2 diabetes mellitus
2007-004438-18Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nebivolol and carvedilol in orthostatic hypotension (OH), hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Menarini Group. Primary endpoint: Primary efficacy endpoint. Started Jan 2008; status: completed.
02
Drugs
nebivololcarvedilol
03
Conditions
orthostatic hypotension (OH)hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-004438-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004438-18.